Pharmacyclics

NCT05963074

Collaborator, Phase 2, Active, not recruiting, 2024, 333 people, 27 Jul 2023, clinicaltrials.gov

NCT05564052

Collaborator, Phase 2, Completed, 2022, 36 people, 3 Oct 2022, clinicaltrials.gov

NCT05431179

Collaborator, Phase 3, Withdrawn, 2023, 0 people, 24 Jun 2022, clinicaltrials.gov

NCT04450173

Collaborator, Phase 2, Active, not recruiting, 2021, 40 people, 29 Jun 2020, clinicaltrials.gov

NCT04273139

Collaborator, Phase 2, Active, not recruiting, 2020, 45 people, 17 Feb 2020, clinicaltrials.gov

NCT04235036

Collaborator, Phase 2, Terminated, 2019, 15 people, 21 Jan 2020, clinicaltrials.gov

NCT04212013

Collaborator, Phase 3, Active, not recruiting, 2019, 23 people, 26 Dec 2019, clinicaltrials.gov

NCT03790332

Phase 1/2, Completed, 2018, 59 people, 31 Dec 2018, clinicaltrials.gov

NCT03703167

Collaborator, Phase 1, Completed, 2019, 25 people, 11 Oct 2018, clinicaltrials.gov

NCT03702725

Collaborator, Phase 1, Completed, 2019, 14 people, 11 Oct 2018, clinicaltrials.gov

NCT03646461

Collaborator, Phase 2, Terminated, 2018, 5 people, 24 Aug 2018, clinicaltrials.gov

NCT03462719

Collaborator, Phase 3, Active, not recruiting, 2018, 211 people, 12 Mar 2018, clinicaltrials.gov

NCT03422393

Collaborator, Phase 1, Active, not recruiting, 2018, 24 people, 5 Feb 2018, clinicaltrials.gov

NCT03379428

Collaborator, Phase 1/2, Active, not recruiting, 2017, 34 people, 20 Dec 2017, clinicaltrials.gov

NCT03359460

Collaborator, Phase 1, Completed, 2017, 4 people, 2 Dec 2017, clinicaltrials.gov

NCT03267186

Collaborator, Phase 2, Completed, 2017, 8 people, 30 Aug 2017, clinicaltrials.gov

NCT03229200

Phase 4, Active, not recruiting, 2017, 297 people, 25 Jul 2017, clinicaltrials.gov

NCT03207555

Collaborator, Phase 2, Completed, 2018, 23 people, 2 Jul 2017, clinicaltrials.gov

NCT03198026

Collaborator, Phase 2, Active, not recruiting, 2018, 29 people, 23 Jun 2017, clinicaltrials.gov

NCT03145480

Collaborator, Phase 2, Terminated, 2017, 3 people, 9 May 2017, clinicaltrials.gov